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HSV infection blocks G1 events in the cell cycle and arrests host cell growth in the G1 phase. To further define the
mechanism of the effect and determine the viral gene product(s) responsible, we examined various mutant viruses for their
effects on cell cycle regulatory proteins (pRb, cyclin D1, and cdk4) and on cell cycle progression into S phase. Unlike the
wild-type virus, the ICP27 mutant virus was defective for blocking the phosphorylation of pRb proteins, and the normal pRb
pattern was restored in cells infected with a rescued virus. The virion host shutoff (vhs) function, DNA replication, and late
gene functions were not required for the virus-induced effects on pRb protein. BrdU incorporation in synchronized
HSV-infected cells showed that ICP27 was required for blocking the cell cycle in the G1 phase. Furthermore, ICP27, ICP4,
ICP0, and vhs were required for blocking the induction of the G1 cell cycle regulators cyclin D1 and cdk4 in HSV-infected
cells. Both ICP27 and the vhs function contributed to the reduction of cyclin D1 mRNA levels in HSV-infected cells. These
results provide evidence that HSV-1 ICP27 protein is essential for viral inhibition of G1-phase functions and that certain other
HSV proteins are required for some of the viral effects on the cell cycle. Finally, these results show that HSV-1 ICP27 and
vhs act jointly to reduce host mRNA levels in infected cells. © 2001 Academic Press
INTRODUCTION
Infection with herpes simplex virus (HSV) profoundly
alters the host cell and its synthetic machinery, redirect-
ing the cell from synthesis of cellular proteins to synthe-
sis of viral proteins. HSV encodes several genes that are
involved in priming the newly infected cells to support
efficient viral replication. This virus-induced switch in
gene expression involves destabilization of host mRNAs,
repression of host transcription, and inhibition of RNA
splicing (reviewed by Roizman and Knipe, 2001). Further-
more, HSV infection alters the cell cycle regulatory mol-
ecules and mechanisms in many ways.
A variety of virion-associated regulatory proteins lo-
cated in the tegument are delivered into the cytoplasm
after fusion of the viral envelope with the host cell
plasma membrane. VP16 is an abundant tegument pro-
tein and stimulates transcription of the viral immediate-
early genes (Batterson and Roizman, 1983; Campbell et
al., 1984; Pellett et al., 1985; Post et al., 1981). The virion
host shutoff (vhs) protein, another tegument protein,
causes degradation of mRNAs and triggers rapid shutoff
of host cell protein synthesis in the cytoplasm (Fenwick
and McMenamin, 1984; Read and Frenkel, 1983; Schek
and Bachenheimer, 1985; Strom and Frenkel, 1987). In
addition, HSV infection inhibits transcription of many
host genes (Long et al., 1999; Rice et al., 1994, 1995;
Spencer et al., 1997). Viral immediate-early proteins
(ICP0, ICP4, ICP22, and ICP27) are expressed first upon
infection (Batterson and Roizman, 1983) and they act
cooperatively to regulate the expression of all classes of
viral genes (reviewed by Roizman and Knipe, 2001).
HSV replicates well in all phases of the cell cycle (Cai
and Schaffer, 1991; Roizman and Knipe, 2001; Yeh and
Knipe, unpublished results). Furthermore, HSV encodes
seven proteins essential for viral DNA synthesis, includ-
ing a viral DNA polymerase as well as functional ho-
mologs of several S-phase functions, including ribonu-
cleotide reductase and thymidine kinase, further arguing
that cellular S phase is not required for an efficient
infection. Several different effects of HSV infection on the
cell cycle have been reported. First, we had shown that
HSV infection blocks cell-cycle progression into S phase
(de Bruyn Kops and Knipe, 1988). Second, a study con-
cluded that HSV-2 infection leads to increased phosphor-
ylation of pRb and transient activation of cyclin-depen-
dent kinase 2 (cdk2) activity, which would be consistent
with cells moving into S phase (Hossain et al., 1997).
Third, it has been reported that HSV-1 ICP0 protein binds
to and stabilizes cyclin D3 (Kawaguchi et al., 1997) and
that cyclin-dependent kinases are required for HSV rep-
lication and transcription (Jordan et al., 1999; Schang et
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al., 1998, 1999, 2000), possibly indicating a need for
cell-cycle progression during viral infection. Recently,
several studies have shown that HSV infection blocks G1
events and arrests host cell growth in G1 phase (Eh-
mann et al., 2000; Olgiate et al., 1999; Song et al., 2000).
Progression of the cell cycle from G0 to S phase is
regulated by a series of events, including the sequential
assembly, activation, and subsequent inactivation of a
series of cyclin/cdk complexes (Pines, 1993). The expres-
sion of D-type cyclins is stimulated by growth factors and
mitogens (Bates et al., 1994; Matsushime et al., 1992;
Myerson and Harlow, 1994). The D-type cyclins associate
with and activate the cyclin-dependent kinases cdk2,
cdk4, cdk5, and cdk6 (Matsushime et al., 1992; Myerson
and Harlow, 1994; Xiong et al., 1992). D-type cyclin/cdk
complexes play a major role in phosphorylation of the
retinoblastoma protein (pRb), which is required for the
G1- to S-phase transition (Sherr, 1993, 1994). pRb is
found in a hypophosphorylated form in quiescent cells
and early G1 phase and then becomes phosphorylated
on several cdk consensus sites during mid- to late G1.
The hypophosphorylated form of pRb binds to and inhib-
its several cellular proteins whose products are required
for S-phase progression (reviewed by Nevins, 1994;
Weinberg, 1995).
We have shown that HSV infection leads to an inhibi-
tion of G1-phase-specific events, including blocking the
phosphorylation of pRb and blocking the induction of
cyclin D1 and cdk4, important G1-phase regulators (Song
et al., 2000). To determine the viral gene products re-
sponsible for this effect, we examined the cells infected
with several mutant viruses with mutations in four imme-
diate-early proteins, vhs function, or a DNA replication
function. Our results demonstrate that HSV-1 ICP27,
ICP4, and ICP0 functions contribute to blocking the in-
duction of cyclin D1 and cdk4 proteins in HSV-infected
cells and that HSV-1 ICP27 protein is required for block-
ing the phosphorylation of pRb protein and for blocking
the cell cycle in the G1 phase.
RESULTS
The virion host shutoff function is not required for the
effects of HSV infection on pRb
HSV infection blocks G1 events in the cell cycle and
arrests host cell growth in the G1 phase (de Bruyn Kops
and Knipe, 1988; Ehmann et al., 2000; Song et al., 2000).
To determine the viral gene product(s) responsible for
this effect, we examined various HSV-1 mutant strains for
their effects on the cell cycle regulatory proteins (pRb,
cyclin D1, and cdk4) and on cell cycle progression into S
phase.
Immediately after infection, the vhs function destabi-
lizes mRNAs in the cytoplasm and contributes to redi-
recting the cell from synthesis of cellular to synthesis of
viral proteins (Fenwick and McMenamin, 1984; Read and
Frenkel, 1983; Schek and Bachenheimer, 1985; Strom
and Frenkel, 1987).
To determine if the vhs function played a role in the
effects of HSV infection on pRb, we infected CV-1 cells
with vhs mutant or wild-type virus, prepared total cell
extracts, and examined pRb proteins by immunoblotting
(Fig. 1A). As described previously (Song et al., 2000), pRb
proteins were hypophosphorylated in G0 phase and
shifted toward slower-migrating, hyperphosphorylated
forms as cells moved into G1 phase, while wild-type HSV
infection blocked the shift and the majority of pRb re-
mained as hypophosphorylated species (Fig. 1A). The
vhs mutant virus (vhs) was as effective as wild-type virus
(KOS) in shifting pRb proteins toward hypophosphory-
lated forms, while an ICP27 mutant virus (5dl1.2) was
defective for downshifting pRb proteins (Fig. 1A). To en-
sure that the vhs mutant virus was defective for inhibition
of host protein synthesis, we examined protein synthesis
in infected and mock-infected cells (Fig. 1B). While host
protein synthesis was inhibited in cells infected with
wild-type virus, host protein synthesis was much less
affected in cells infected with the vhs mutant virus under
normal infection conditions (Fig. 1B, lanes 1 to 3) or in the
presence of actinomycin D to inhibit transcription (Fig.
1B, lanes 4 to 6). Thus, the vhs mutant virus infection
blocked pRb phosphorylation even though host shutoff
was defective.
Viral DNA replication and late gene functions are not
required for the effects of HSV infection on pRb
Expression of HSV-1 genes during a lytic infection
proceeds in a temporally ordered cascade, and the late
genes require viral DNA synthesis for maximal induction
(Honess and Roizman, 1974, 1975; Roizman and Knipe,
2001; Wagner, 1985). To determine if viral DNA replication
and late gene functions were involved in the effects of
HSV infection on pRb, we infected CV-1 cells with an
HSV-1 mutant virus defective for the HSV DNA replication
protein ICP8 (HD2) or with KOS and examined pRb pro-
tein by immunoblotting (Fig. 2). The mutant virus HD2
was as effective as the wild-type virus in blocking the
phosphorylation of pRb during infection (Fig. 2, lanes 3
and 5). Similarly, wild-type virus infection in the presence
of an inhibitor of viral DNA replication, PAA, effectively
blocked the phosphorylation of pRb proteins (Fig. 2, lane
4). These results indicated that ICP8, viral DNA replica-
tion, and true late gene functions are not required for the
effects of HSV infection on pRb.
An ICP27 mutant strain is unable to block the
formation of hyperphosphorylated forms of pRb
in infected cells
To examine the roles of viral immediate-early genes on
the HSV-induced cell cycle block, we infected CV-1 cells
with wild-type HSV-1 KOS or KOS mutant strains with
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mutations in each of four viral immediate-early genes
(ICP0, ICP4, ICP22, or ICP27), prepared total cell ex-
tracts, and examined pRb by immunoblotting (Fig. 3). pRb
proteins were hypophosphorylated in G0 phase and
shifted toward slower-migrating, hyperphosphorylated
forms as cells moved to G1 phase (Fig. 3, lanes 1 and 2).
Wild-type HSV infection blocked the shift, and the major-
ity of pRb remained as hypophosphorylated species,
bands a and b (Fig. 3, lane 3). However, an ICP27 mutant
(5dl1.2) (Fig. 3, lane 4) failed to block the formation of the
FIG. 1. Effect of virion host shutoff (vhs) function on the phosphorylation of pRb protein during HSV infection. (A) Following growth arrest induced
by serum starvation, CV-1 cells were infected with an HSV-1 strain as indicated or mock infected as a control and overlaid with DMEM–10% serum.
Total cell extracts, harvested at 0 or 10 h p.i., were examined for pRb by immunoblot analysis. Mock, mock-infected; KOS, wild-type HSV-1; vhs, HSV-1
virion host shutoff mutant; and 5dl1.2, HSV-1 ICP27 mutant. (B) Effect of vhs function on host protein synthesis. Cycling CV-1 cells were infected with
HSV-1 strains at an m.o.i. of 20 or mock infected as a control and overlaid with DMEM–10% serum for 6.5 h in the absence () and presence () of
the inhibitor of RNA synthesis actinomycin D. Prior to preparing total cell extracts at 6.5 h p.i., the cells were labeled for 1 h with [35S]Met, Cys in
minimal essential medium containing 1% serum. pRb bands are labeled as described in Song et al. (2000).
FIG. 2. Effect of viral DNA replication on the phosphorylation of pRb
protein during HSV infection. Following growth arrest induced by serum
starvation, CV-1 cells were infected with an HSV-1 strain as indicated
or mock infected as a control and overlaid with DMEM–10% serum.
Total cell extracts, harvested at 0 or 10 h p.i., were examined for pRb by
immunoblot analysis. Mock, mock-infected; KOS, wild-type HSV-1;
KOSPAA, infected with KOS in the presence of PAA, the inhibitor of
viral DNA synthesis; and HD2, HSV-1 ICP8 mutant.
FIG. 3. Phosphorylation pattern of the retinoblastoma protein (pRb) in
cells infected with HSV-1 mutants with mutations in immediate-early
genes. CV-1 cells were growth arrested by culturing in DMEM contain-
ing 1% calf serum for 48 h to synchronize them in G0 phase and
infected with an HSV-1 strain as indicated or mock infected as a
control. At 1 h p.i., all cells were overlaid with DMEM containing 10%
serum. Total cell extracts were prepared at 0 and 10 h postinfection and
processed for immunoblotting analysis for pRb protein, as described
previously. Mock, mock-infected; KOS, wild-type HSV-1; 5dl1.2, HSV-1
ICP27 mutant; n212, HSV-1 ICP0 mutant; n12, HSV-1 ICP4 mutant; and
n199, HSV-1 ICP22 mutant.
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hyperphosphorylated pRb forms, bands c and d, while
the ICP0 (n212), ICP4 (n12), and ICP22 (n199) mutants
showed wild-type phenotypes (Fig. 3, lanes 5, 6, and 7).
To confirm that ICP27 was specifically required for the
effects of HSV infection on pRb, we repaired the mutation
of KOS1.1 d27-1 (Rice and Knipe, 1990), which has the
same deletion as KOS 5dl1.2 (McCarthy et al., 1989) (Fig.
4). We cotransfected the complementing V827 cells with
d27-1 DNA and plasmid pPs27pd1 DNA, which contains
the wild-type ICP27 gene (Fig. 4A). Progeny viruses were
plated on Vero cells to select viral recombinants in which
the deletion had been repaired by recombination. After
three rounds of plaque purification on Vero cells, we
confirmed the wild-type ICP27 locus in the rescued virus,
d27-1R, by Southern hybridization (Fig. 4B) and examined
pRb from the extracts from the cells infected with the
wild-type, mutant, or rescued virus by immunoblot anal-
ysis (Fig. 4C). The ICP27-rescued virus, d27-1R, blocked
the phosphorylation of pRb protein like the wild-type
virus, indicating that ICP27 was required for blocking the
phosphorylation of pRb in HSV-infected cells. These re-
sults also showed similar phenotypes with independent
ICP27 mutants, 5dl1.2 and d27-1, further confirming the
role of ICP27 in regulating the phosphorylation of pRb
protein in HSV-infected cells.
Cyclin D1 and cdk4 expression during infection
with HSV-1 strains with mutations
in immediate-early genes
D-type cyclin/cdk complexes play a major role in the
phosphorylation of pRb (Sherr, 1994), which is required
for the G1- to S-phase transition. To determine if viral
immediate-early gene products (ICP0, ICP4, ICP22, and
ICP27) exerted any effect on the induction of cyclin D1
and cdk4, we infected CV-1 cells with wild-type or mutant
viruses and examined cyclin D1 and cdk4 from the cell
extracts by immunoblotting (Figs. 5 and 6). As cells
moved from G0 to G1 phase, the levels of cyclin D1
increased (Fig. 5A, lanes 1 to 4, and Fig. 5B, lanes 1 and
2). While the wild-type (KOS), ICP0 mutant (n212), and
ICP22 mutant (n199) viruses were able to block the
induction of cyclin D1 (Fig. 5B, lanes 3, 4, and 6), the ICP4
FIG. 4. Rescue of an ICP27 mutant virus and analysis of pRb protein in cells infected with the rescued virus. (A) Genome structure of wild-type HSV-1
strain KOS1.1 and the DNA regions of the plasmid pPs27pd1 and the ICP27-deletion mutant virus (d27-1) are depicted. (B) Southern blot analysis of
the genome structures of the wild-type (KOS1.1), ICP27 mutant (d27-1), and rescued virus (d27-1R). The viral DNAs were digested with PstI, separated
in a 0.8% agarose gel, and processed for Southern blot analysis using an ICP27 gene-specific probe, a 6.1-kb PstI fragment from pPs27pd1. A 6.1-kb
PstI fragment was detected in the viral DNAs from KOS1.1 and d27-1R infection and a smaller fragment detected in the viral DNAs from d27-1 infection.
(C) Immunoblot analysis for pRb protein. Total cell extracts were prepared from the infected cells at 11 h postinfection, separated on SDS–PAGE, and
processed for immunoblot analysis for pRb protein, as described in the legend to Fig. 1.
FIG. 5. Cyclin D1 protein levels in cells infected with HSV-1 mutants
with mutations in the viral immediate-early genes. (A) Following growth
arrest induced by serum starvation, CV-1 cells were grown in DMEM
containing 10% serum and total cell extracts were prepared at 0, 3, 6,
9, 12, and 15 h after the release from serum starvation, followed by
immunoblot analysis for cyclin D1. (B) Following growth arrest induced
by serum starvation, CV-1 cells were infected with the indicated HSV-1
strain or mock infected as a control and overlaid with DMEM–10%
serum. Total cell extracts, harvested at 0 or 10 h p.i., were examined for
cyclin D1 by immunoblot analysis. Mock, mock-infected; KOS, wild-type
HSV-1; n212, HSV-1 ICP0 mutant; n12, HSV-1 ICP4 mutant; n199, HSV-1
ICP22 mutant; and 5dl1.2, HSV-1 ICP27 mutant.
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(n12) and ICP27 (5dl1.2) mutant viruses were at least
partially defective for this effect (Fig. 5B, lanes 5 and 7).
As cells moved from G0 to G1 phase, the levels of cdk4
increased (Fig. 6A, lanes 1 to 4, and Fig. 6B, lanes 1 and
2). While the wild-type (KOS) and ICP22 mutant (n199)
viruses were able to block the induction of cdk4 (Fig. 6B,
lanes 3 and 6), the ICP0 (n212), ICP4 (n12), and ICP27
(5dl1.2) mutant viruses were defective for blocking the
induction (Fig. 6B, lanes 4, 5, and 7).
These results indicated that ICP27, ICP4, and ICP0
were required for blocking the induction of cyclin D1 and
cdk4.
The effects of the ICP27 and vhs functions on the
levels of cyclin D1 and cdk4 proteins were examined in
the infected cells (Fig. 7). Wild-type HSV infection
blocked the induction of cyclin D1 and cdk4 but the
ICP27 mutant virus was not able to block the induction
(Figs. 7A and 7B, lanes 3 and 4). The effect of vhs
function on cyclin D1 and cdk4 proteins was slightly less
significant than the ICP27 function (Figs. 7A and 7B,
lanes 4 and 5). These results demonstrated that the
effects of HSV infection on the G1 regulatory proteins
cyclin D1 and cdk4 were not due entirely to the general
host shutoff function of the virion protein vhs and indicate
that viral immediate-early protein ICP27 also plays an
essential role in this process.
ICP27 plays an essential role in blocking the infected
cells in the G1 phase
To confirm the role for ICP27 in cell cycle arrest, we
synchronized CV-1 cells by mitotic shake-off and moni-
tored the progression of the cell cycle by incorporation of
the thymidine analogue BrdU into DNA and detection of
newly synthesized DNA using an immunofluorescence
assay. Preliminary results showed that the midpoint of
G1 phase was 6 h after the mitotic shake-off and the
midpoint of S phase was 13.5 h after the shake-off (Yeh
and Knipe, unpublished results). Infection of G1-phase
cells with wild-type HSV (KOS1.1) in the presence of PAA,
an inhibitor of viral DNA synthesis, caused a threefold
reduction in the number of cells staining with anti-BrdU
antibody, compared with mock infection (Fig. 8, left). In
contrast, infection with d27-1 did not reduce the number
of cells entering S phase (Fig. 8, left).
Once cells had moved into S phase, infection with
wild-type or d27-1 virus did not alter the number of cells
synthesizing DNA (Fig. 8, right). These results confirm
the previous observation that HSV infection inhibits the
cell cycle progression from G1 to S phase (de Bruyn
Kops and Knipe, 1988; Ehmann et al., 2000; Song et al.,
2000). These results together demonstrate that ICP27 is
required for the inhibitory effect of HSV infection on cell
cycle progression.
Possible mechanisms for the cell cycle block induced
during HSV infection
To determine the viral gene products involved in reg-
ulating the expression of cyclin D1 mRNA, total cellular
RNA was prepared from CV-1 cells infected with various
HSV strains or from mock-infected cells as a control and
processed for Northern blot analysis of cyclin D1 mRNA
(Fig. 9). As cells moved from the G0 phase to G1 phase,
the levels of cyclin D1 RNA increased (Fig. 9, lanes 1 and
2). Upon wild-type HSV infection, cyclin D1 RNA was
significantly reduced to levels below that in G0 phase
(Fig. 9, lane 3). In cells infected with the vhs mutant (Fig.
9, lane 4) or the ICP27 mutant (Fig. 9, lane 5), only a
partial reduction in cyclin D1 mRNA was observed.
These results indicated that both the vhs function and
FIG. 7. ICP27 protein plays an essential role in regulating the ex-
pression of cyclin D1 and cdk4. Following growth arrest induced by
serum starvation, CV-1 cells were infected with the indicated HSV-1
strain or mock infected as a control and overlaid with DMEM–10%
serum. Total cell extracts, harvested at 0 or 10 h p.i., were examined for
cyclin D1 (A) and cdk4 (B) by immunoblot analysis. Mock, mock-
infected; KOS, wild-type HSV-1; 5dl1.2, HSV-1 ICP27 mutant; and vhs,
HSV-1 virion host shutoff mutant.
FIG. 6. Cyclin-dependent kinase 4 (cdk4) protein levels in cells
infected with HSV-1 mutants with mutations in the viral immediate-early
genes. (A) Following growth arrest induced by serum starvation, CV-1
cells were grown in DMEM containing 10% serum and total cell ex-
tracts were prepared at 0, 3, 6, 9, 12, and 15 h after the release from
serum starvation, followed by immunoblot analysis for cdk4. (B) Fol-
lowing growth arrest induced by serum starvation, CV-1 cells were
infected with the indicated HSV-1 strain or mock infected as a control
and overlaid with DMEM–10% serum. Total cell extracts, harvested at 0
or 10 h p.i., were examined for cdk4 by immunoblot analysis. Mock,
mock-infected; KOS, wild-type HSV-1; n212, HSV-1 ICP0 mutant; n12,
HSV-1 ICP4 mutant; n199, HSV-1 ICP22 mutant; and 5dl1.2, HSV-1 ICP27
mutant.
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ICP27 contributed to blocking the induction of cyclin D1
RNA.
DISCUSSION
Several studies have shown that HSV infection inhibits
G1-specific events and blocks the infected cells in the
G1 phase (de Bruyn Kops and Knipe, 1988; Ehmann et al.,
2000; Olgiate et al., 1999; Song et al., 2000). To determine
what viral gene product(s) was involved in this process,
we examined several mutant viruses with mutations in
each of the immediate-early proteins, vhs function, and
viral DNA replication. We observed that ICP0, ICP4, and
ICP27 mutant viruses were defective for blocking the
induction of cyclin D1 and cdk4 proteins. The ICP27
mutant virus was defective for blocking the induction of
cyclin D1 mRNAs, for blocking the phosphorylation of
pRb proteins, and for blocking cell cycle transition from
G1 to S phase. Cyclin D1 and cdk4 are major regulatory
proteins during G1 progression and form a holoenzyme
complex with kinase activity. Cyclin D1/cdk4 kinase
phosphorylates pRb, a necessary modification for pro-
gression of the cells to S phase. The lack of the essential
components of the G1 cyclin/cdk holoenzyme complexes
in the HSV-infected cells is consistent with the reduced
phosphorylation of pRb and the cell-cycle block in G1
phase. However, the HSV-1 vhs mutant virus also failed
to decrease levels of cyclin D1 mRNA to the same extent
as the ICP27 mutant virus, but the vhs mutant virus
blocked pRb phosphorylation similar to wt virus. There-
fore, while host shutoff may play a role in blocking G1
events, ICP27 appears to have a distinct function that is
necessary for blocking or decreasing pRb phosphoryla-
tion.
Multiple viral functions are involved in regulating the
expression of G1 proteins
Phosphorylation of pRb in the ICP27-mutant-infected
cells was not equivalent to that in mock-infected cells.
FIG. 8. Effect of HSV infection on cell cycle progression. CV-1 cells were synchronized by mitotic shake-off and plated in DMEM–10% fetal calf
serum. Virus infection or mock infection was initiated in the G1 phase (left), 6.5 h after plating, or in the S phase (right), 13.5 h after plating. Cells were
mock infected or infected for 5 h with the wild-type (KOS1.1) or the ICP27 mutant (d27) in the presence of the inhibitor of viral DNA replication
phosphonoacetic acid (400 g/ml), for 5 h. Cells were then labeled with BrdU for 15 min and immunostained with anti-BrdU antibody. The percentage
of cells stained for BrdU in each culture is shown. Lanes labeled mock (pre) were labeled before the 5-h mock infection.
FIG. 9. Northern blot analysis of cyclin D1 mRNA in HSV-infected
cells. Following growth arrest induced by serum starvation, CV-1 cells
were infected with the indicated HSV-1 strain or mock infected as a
control and overlaid with DMEM–10% serum. Total cell RNAs, har-
vested at 0 or 10 h p.i., were examined for cyclin D1 mRNA by Northern
blot analysis. Mock, mock-infected; KOS, wild-type HSV-1; vhs, HSV-1
virion host shutoff mutant; and 5dl1.2, HSV-1 ICP27 mutant.
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This suggests that other viral proteins may be involved in
blocking the phosphorylation of pRb. Indeed, the ICP4
mutant was partially defective for blocking the phosphor-
ylation of pRb proteins, suggesting the role of the ICP4
protein. Furthermore, several viral immediate-early gene
products including ICP0, ICP4, and ICP27 and virion
protein vhs were involved in inhibiting the expression of
cyclin D1 and cdk4 proteins, which are important G1
regulators responsible for the phosphorylation of pRb.
However, vhs, viral DNA replication, and possibly true
late gene functions were not required for blocking the
phosphorylation of pRb in HSV-infected cells.
When we examined the expression of cyclin D1 mRNA
in HSV-infected cells, the wild-type virus blocked the
induction of cyclin D1 RNA even below the level in the
mock-infected cells at the G0 phase. In the cells infected
with the vhs mutant or the ICP27 mutant, expression of
cyclin D1 RNA was partially restored. These results in-
dicate that both vhs and ICP27 functions contributed to
blocking the expression of cyclin D1 RNA in HSV-in-
fected cells. The effects of vhs and ICP27 mutations on
the levels of cyclin D1 RNA and protein are consistent
with the idea that vhs degrades RNA in the cytoplasm
right after infection and shuts off the synthesis of host
proteins (Fenwick and McMenamin, 1984; Read and
Frenkel, 1983; Schek and Bachenheimer, 1985; Strom
and Frenkel, 1987) and that ICP27 inhibits host cell RNA
splicing (Hardwicke and Sandri-Goldin, 1994; Hardy and
Sandri-Goldin, 1994) and/or host cell transcription (Long
et al., 1999; Rice et al., 1994, 1995; Spencer et al., 1997).
These results argue that both vhs and ICP27 are required
for viral inhibition of host gene expression and suggest
that both are required for viral inhibition of host cell
responses to viral infection.
Potential mechanisms for the cell cycle block induced
during HSV infection
It is likely that HSV affects the host cell cycle in
multiple ways through its effects on several cellular
events such as transcription, splicing, and regulation of
protein stability. The shift in transcription from cellular to
viral genomes may involve several mechanisms such as
modifications to the RNA polymerase II transcription ma-
chinery, alterations in DNA conformation, or localization
of viral genes in specialized nuclear compartments. It
has been reported that HSV represses host RNA poly-
merase II transcription (Spencer et al., 1997) and that
HSV immediate-early protein ICP22 is required for virus-
induced modification of host RNA polymerase II (Long et
al., 1999; Rice et al., 1994, 1995). Also, it has been re-
ported that the viral immediate-early protein ICP4 inter-
acts with the TATA box binding protein, TFIIB, and
TAF250 (Carrozza and DeLuca, 1996; Smith et al., 1993).
Finally, it is known that HSV immediate-early protein
ICP27 inhibits host cell RNA splicing (Hardwicke and
Sandri-Goldin, 1994; Hardy and Sandri-Goldin, 1994) and
is required for inhibition of host gene transcription (Spen-
cer et al., 1997). These effects could contribute to the
viral inhibition of G1 gene expression and block in the G1
stage of the cell cycle.
Although the role of ICP27 in blocking expression of
cyclin D and cdk4 is consistent with blocking progres-
sion of G1, vhs exerts a similar effect on cyclin D mRNA
levels without blocking phosphorylation of pRb. Thus, it
appears that ICP27 exerts an effect on progression of the
cell cycle in addition to blocking induction of expression
of these two gene products. These results are consistent
with the observation that the human cytomegalovirus
ICP27 homolog UL69 can block the cell cycle in G1
phase (Lu and Shenk, 1999).
There are several possible mechanisms by which
ICP27 could otherwise affect progression of the cell
cycle and phosphorylation of pRb. First, it could inhibit
the expression of cell cycle gene products other than
those assayed in this work. Second, it could inhibit the
activity of kinases necessary for cell cycle progression
and pRb phosphorylation. In this regard, ICP27 has been
shown to interact with casein kinase II (Wadd et al.,
1999). Third, ICP27 could stimulate the activity of phos-
phatases so that pRb or other molecules are more
readily dephosphorylated. ICP27 has been shown to
decrease or alter the phosphorylation of ICP4 (Rice and
Knipe, 1988; Su and Knipe, 1989; Xia et al., 1996) and the
splicing factor SC35 (Sandri-Goldin and Hibbard, 1996).
Further studies are needed to determine the portions of
ICP27 needed for this effect and the biochemical activi-
ties associated with that domain.
MATERIALS AND METHODS
Viruses and cells
The parental HSV-1 wild-type strains KOS and KOS1.1
were obtained from P. Schaffer and M. Levine, respec-
tively. The ICP0 mutant (n212), ICP4 mutant (n12), ICP22
mutant (n199), and ICP27 mutant (5dl1.2) viruses were all
derived from KOS and were provided by P. Schaffer (Beth
Israel–Deaconess Hospital, Boston, MA). The ICP27 mu-
tant (d27-1), derived from KOS1.1, was described previ-
ously (Rice and Knipe, 1990). The virion host shutoff
mutant (vhs-1) was derived from KOS and was provided
by S. Read (Read and Frenkel, 1983). The ICP8 mutant
(HD2), derived from KOS1.1, was described previously
(Gao and Knipe, 1989). CV-1 monkey kidney cells (Amer-
ican Type Culture Collection, Rockville, MD) were grown
as described in Dulbecco’s modified minimal essential
medium (Cellgro, Atlanta, GA), supplemented with 5%
fetal bovine serum (Gibco BRL, Grand Island, NY) and 5%
newborn calf serum (Hyclone, Provo, UT) as described
(Knipe and Spang, 1982). Cells were infected at an m.o.i.
of 20. Cells were growth arrested by incubation in 199
medium containing 1% calf serum for 24 to 48 h. Prior to
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incubation in this medium, 48% of the cells were labeled
with BrdU and in S phase. After 24 h incubation in the 199
medium, less than 4% of the cells were labeled with
BrdU, indicating a cell-cycle arrest.
Antibodies
The antibodies used for immunoblotting pRb, cyclin
D1, and cdk4 were as follows. Mouse anti-pRb monoclo-
nal antibody (PharMingen 14001A) was used at a 1:1000
dilution. Mouse anti-cyclin D1 monoclonal antibody
(Santa Cruz Biotechnology, Santa Cruz, CA; sc-8396) was
used at a 1:500 dilution. Rabbit anti-cdk4 polyclonal an-
tibody (Santa Cruz sc-260) was used at a 1:1000 dilution.
Immunoblot analysis
The harvested cell pellets, from mock-infected and
HSV-infected cells, were lysed in SDS-containing sample
buffer [62.5 mM Tris–HCl, pH 6.8; 2% (w/v) SDS; 20%
glycerol; 0.5% (v/v) 2-mercaptoethanol; 0.1% (w/v) bromo-
phenol blue]. Proteins in the cell lysate were resolved by
SDS–PAGE (Knipe and Spang, 1982) and electrophoreti-
cally transferred from the gels onto nitrocellulose filters
in a transfer apparatus according to the procedures of
the manufacturer (Bio-Rad). Expression of pRb, cyclin D1,
and cdk4 was monitored by probing the blots with the
primary antibodies described earlier, followed by horse-
radish peroxidase-coupled secondary antibodies (Santa
Cruz Biotechnology) and enhanced chemiluminescence
(Amersham).
Rescue of the ICP27 mutant virus d27-1
ICP8- and ICP27-complementing V827 cells (Da Costa
et al., 2001) were cotransfected with 1 g of d27-1 viral
DNA and 1 g of PstI-digested plasmid pPs27pd1 (Rice
et al., 1989), which contains the wild-type ICP27 gene,
using Lipofectamine (Life Technologies 18324-012) ac-
cording to the procedures of the manufacturer. At 4 days
posttransfection, the transfected cells were harvested
following the formation of plaques. Progeny viruses were
plated on Vero cells to select wt recombinants. After
three rounds of plaque purification on Vero cells, a viral
stock of the rescued virus, d27-1R, was made for further
analysis. To confirm the genome structure of the rescued
virus, viral DNAs were prepared from the infected cells
using the DNeasy Tissue Kit (Qiagen 69504) according to
the procedures of the manufacturer, digested with PstI,
and processed for Southern blot analysis using an ICP27
gene-specific probe. The probe was labeled with
[32P]dCTP using the RadPrime DNA Labeling System
(Life Technologies).
35S labeling of proteins
CV-1 cells in a 25-mm2 flask were mock infected or
infected with HSV and incubated in 2 ml of medium
containing 100 Ci of Tran35S-Label (ICN 51006, 1175
Ci/mmol) containing [35S]methionine (70%) L-[35S]cysteine
(15%) for 1 h from 5.5 to 6.5 h p.i. Then, the cell lysates
were separated on SDS–PAGE and processed for auto-
radiography.
BrdU labeling of the cells synchronized by mitotic
shake-off
CV-1 cells were synchronized by mitotic shake-off and
plated in DMEM–10% fetal calf serum. Virus infection or
mock infection was initiated in the G1 phase, 6.5 h after
plating, or in the S phase, 13.5 h after plating. Cells were
mock infected or infected with the wild-type (KOS1.1) or
the ICP27 mutant (d27) in the presence of sodium phos-
phonoacetate (400 g/ml) for 5 h. Cells were then la-
beled with BrdU for 15 min and immunostained with
anti-BrdU antibody.
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